Meet Our 2022 Chief Innovation Officer – Family Heart

The Family Heart Foundation is excited to announce that Hilliard “Hilly” Paige, Jr. is joining the team as the Chief Innovation Officer.

Hilly brings over 30 years of leadership experience in the Biopharmaceutical industry, including leading patient and professional advocacy functions, new product franchises, product development, strategic planning and launch strategies for products in the cardiovascular, metabolic, transplant and immunologic marketplaces.

“Hilly’s deep knowledge of healthcare and his ongoing commitment to creative solutions is consistent with the Family Heart Foundation’s mission and vision,” says Katherine Wilemon, CEO and Founder of the Family Heart Foundation. “He is dedicated to assuring that every person born at high risk of cardiovascular disease can receive the information and care they need. He will be a great addition to our amazing team and the innovative work we are doing to significantly improve healthcare in the United States.”

Most recently, Hilly was the Vice-President of Marketing for Esperion Therapeutics. Prior to Esperion, Hilly held positions of increasing responsibility in Sales, US Marketing, Global Marketing, and Advocacy Relations at Amgen, Daiichi-Sankyo, Novartis, and Parke-Davis.

In 2021, Hilly received the Spirit of the Heart Health Equity Champion award from the Association of Black Cardiologists. He has worked with organizations like ABC, the National Medical Association, the National Black Nurses Association, the National Hispanic Medical Association, and the National Minority Health Alliance on initiatives to eliminate disparities and improve health outcomes over the years.

“The Family Heart Foundation occupies a unique place in the healthcare ecosystem by providing unparalleled patient support, provider education, health system collaboration, and data generation and dissemination,” says Hilly. “Improvement of lipid control for high-risk patients in the US will require this sort of innovative multi-pronged approach, and I’m confident that through the efforts of the Family Heart Foundation and its partners, we will see significant improvements in lipid management in the next few years.”

He graduated from Vanderbilt University with a BS degree in Biology/Chemistry and lives with his wife and two sons in Newbury Park, CA.